Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,975,156
in 10 filings, $2.0M under 10b5-1 plans

Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-01 Gassert Chad SVP - CORP. DEV. & STRATEGY Sale 10b5-1 −20,000 $51.06 $1.0M 333,226
2023-07-03 Gassert Chad SVP - CORP. DEV. & STRATEGY Sale 10b5-1 −20,000 $53.43 $1.1M 353,226
2023-06-22 Gassert Chad SVP - CORP. DEV. & STRATEGY Sale 10b5-1 −20,000 $51.32 $1.0M 373,226
2023-02-28 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +17,369 17,369
2023-02-28 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +11,578 28,947
2022-03-21 Gassert Chad SVP - CORP. DEV. & STRATEGY Purchase +5,000 $27.87 $139K 393,226
2022-03-18 Gassert Chad SVP - CORP. DEV. & STRATEGY Purchase +5,000 $27.15 $136K 388,226
2021-11-19 Gassert Chad SVP - CORP. DEV. & STRATEGY Grant or award +383,226 383,226

Page 2 of 2 · 28 trades